The TL analysis methods used to determine absorbed gamma doses in vivo for the BNCT patients treated at FiR 1

Applied Radiation and Isotopes

Volumn 61, Issue 5, 2004, Pages 793-797

  Karila, J ^a   Seppala T ^b   Seren T ^c   Kotiluoto, P ^c   Auterinen, I ^c   Aschan, C ^d   Kankaanranta, L ^e   Savolainen, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Boneca Corporation   (Finland)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

BNCT; Gamma dose; In vivo; TL dosimeter; TPS

Indexed keywords

BORON; GAMMA RAYS; NEUTRON BEAMS; NUMERICAL ANALYSIS; PATIENT MONITORING;

BORON NEUTRON CAPTURE THERAPY (BNCT); GLOW CURVE ANALYSIS; THERMOLUMINESCENT (TL) DOSIMETERS;

DOSIMETRY;

ANALYTIC METHOD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE CALCULATION; GAMMA RADIATION; GLIOBLASTOMA; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; NEUTRON; NEUTRON CAPTURE THERAPY; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; THERMOLUMINESCENCE DOSIMETER; THERMOLUMINESCENCE DOSIMETRY;

BORON NEUTRON CAPTURE THERAPY; FINLAND; GAMMA RAYS; HUMANS; RADIOTHERAPY DOSAGE; THERMOLUMINESCENT DOSIMETRY;

EID: 4143074855     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2004.05.029     Document Type: Conference Paper

References (14)

1. Aschan, C., 1999. Applicability of thermoluminescent dosimeters in X-ray organ dose determination and in the dosimetry of systemic and boron neutron capture radiotherapy. Ph.D. Thesis. Department of Physics, University of Helsinki, Finland.
2. Aschan C., et al. Epithermal neutron beam dosimetry with thermoluminescent dosimeters for boron neutron capture therapy. Radiat. Prot. Dosim. 81(1):1999;47-56
3. Aschan C., et al. Experimental correction for thermal neutron sensitivity of gamma ray TL dosimeters irradiated at BNCT beams. Radiat. Prot. Dosim. 82(1):1999;65-69
4. Burlin T.E. A general theory of cavity ionizations. Br. J. Radiol. 39:1966;727-734
5. Hubbell J. Photon mass attenuation and energy-absorption coefficients from 1keV to 20. MeV Int. J. Appl. Radiat. Isot. 33:1982;1269-1290
6. ICRU Report 46, 1992. Bethesda, MD.
7. Joensuu H., et al. Boron neutron capture therapy of brain tumors. Clinical trials at the Finnish facility using boronophenylalanine J. Neurooncol. 62(1-2):2003;123-134
8. Karila, J., et al., 2000. In vivo dosimetry for BNCT. In: Program & Abstracts of Ninth International Symposium on Neutron Capture Therapy for Cancer, Osaka, Japan, pp. 117-118.
9. Karila, J., et al., 2002. The benefit of in vivo measurements in BNCT. In: Proceedings of the 10th International Congress on Neutron Capture Therapy, Essen, Germany, pp. 517-521.
10. Nigg D.W., et al. SERA - an advanced treatment planning system for neutron therapy and BNCT. Trans. Am. Nucl. Soc. 80:1999;66-68
11. Olko P., et al. Microdosimetric interpretation of the anomalous photon energy response of ultra-sensitive LiF. Mg,Cu,P TL dosemeters Radiat. Prot. Dosim. 47(1):1993;31-35
12. Seppälä, T., 2002. FiR 1 epithermal neutron beam model and dose calculation for treatment planning in neutron capture therapy. Ph.D. Thesis. Department of Physical Sciences, University of Helsinki, Finland.
13. Seppälä T., et al. Dose planning with comparison to in vivo dosimetry for epithermal neutron irradiation of the dog brain. Med. Phys. 29(11):2002;2629-2640
14. Wessol, D., et al., 1997. BNCT_Rtpe: BNCT radiation treatment planning environment user's manual, Version 2.2, http://id.inel.gov/cart/rtpe-manual.